Increase in cortical endocannabinoid signaling in a rat model of basal forebrain cholinergic dysfunction

Neuroscience. 2017 Oct 24:362:206-218. doi: 10.1016/j.neuroscience.2017.08.008. Epub 2017 Aug 18.

Abstract

The basal forebrain cholinergic pathways progressively degenerate during the progression of Alzheimer's disease, leading to an irreversible impairment of memory and thinking skills. The stereotaxic lesion with 192IgG-saporin in the rat brain has been used to eliminate basal forebrain cholinergic neurons and is aimed at emulating the cognitive damage described in this disease in order to explore its effects on behavior and on neurotransmission. Learning and memory processes that are controlled by cholinergic neurotransmission are also modulated by the endocannabinoid (eCB) system. The objective of the present study is to evaluate the eCB signaling in relation to the memory impairment induced in adult rats following a specific cholinergic lesion of the basal forebrain. Therefore, CB1 receptor-mediated signaling was analyzed using receptor and functional autoradiography, and cellular distribution by immunofluorescence. The passive avoidance test and histochemical data revealed a relationship between impaired behavioral responses and a loss of approximately 75% of cholinergic neurons in the nucleus basalis magnocellularis (NBM), accompanied by cortical cholinergic denervation. The decrease in CB1 receptor density observed in the hippocampus, together with hyperactivity of eCB signaling in the NBM and cortex, suggest an interaction between the eCB and cholinergic systems. Moreover, following basal forebrain cholinergic denervation, the presynaptic GABAergic immunoreactivity was reduced in cortical areas. In conclusion, CB1 receptors present in presynaptic GABAergic terminals in the hippocampus are down regulated, but not those in cortical glutamatergic synapses.

Keywords: 192IgG-saporin; CB(1) receptors; GABA; autoradiography; memory; nucleus basalis magnocellularis.

MeSH terms

  • Animals
  • Antibodies, Monoclonal
  • Basal Forebrain / metabolism*
  • Basal Forebrain / pathology
  • Cerebral Cortex / metabolism
  • Cerebral Cortex / pathology
  • Cholinergic Neurons / metabolism*
  • Disease Models, Animal
  • Endocannabinoids / metabolism*
  • Glutamate Decarboxylase / metabolism
  • Guanosine 5'-O-(3-Thiotriphosphate) / metabolism
  • Learning Disabilities / metabolism*
  • Learning Disabilities / pathology
  • Male
  • Memory Disorders / metabolism*
  • Memory Disorders / pathology
  • Nerve Tissue Proteins
  • Random Allocation
  • Rats, Sprague-Dawley
  • Receptor, Cannabinoid, CB1 / metabolism
  • Receptors, Growth Factor
  • Receptors, Nerve Growth Factor / metabolism
  • Ribosome Inactivating Proteins, Type 1
  • Saporins
  • gamma-Aminobutyric Acid / metabolism

Substances

  • 192 IgG-saporin
  • Antibodies, Monoclonal
  • Cnr1 protein, rat
  • Endocannabinoids
  • Nerve Tissue Proteins
  • Receptor, Cannabinoid, CB1
  • Receptors, Growth Factor
  • Receptors, Nerve Growth Factor
  • Ribosome Inactivating Proteins, Type 1
  • Ngfr protein, rat
  • Guanosine 5'-O-(3-Thiotriphosphate)
  • gamma-Aminobutyric Acid
  • Saporins
  • Glutamate Decarboxylase
  • glutamate decarboxylase 2